These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 36849855)

  • 1. Long-term use of metformin and Alzheimer's disease: beneficial or detrimental effects.
    Al-Kuraishy HM; Al-Gareeb AI; Saad HM; Batiha GE
    Inflammopharmacology; 2023 Jun; 31(3):1107-1115. PubMed ID: 36849855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetes drugs in the fight against Alzheimer's disease.
    Boccardi V; Murasecco I; Mecocci P
    Ageing Res Rev; 2019 Sep; 54():100936. PubMed ID: 31330313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin in Alzheimer's disease: An overview of potential mechanisms, preclinical and clinical findings.
    Khezri MR; Yousefi K; Mahboubi N; Hodaei D; Ghasemnejad-Berenji M
    Biochem Pharmacol; 2022 Mar; 197():114945. PubMed ID: 35134385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peripheral insulin-sensitizer drug metformin ameliorates neuronal insulin resistance and Alzheimer's-like changes.
    Gupta A; Bisht B; Dey CS
    Neuropharmacology; 2011 May; 60(6):910-20. PubMed ID: 21277873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iron metabolism in diabetes-induced Alzheimer's disease: a focus on insulin resistance in the brain.
    Chung JY; Kim HS; Song J
    Biometals; 2018 Oct; 31(5):705-714. PubMed ID: 30043289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alzheimer's Disease as Type 3 Diabetes: Common Pathophysiological Mechanisms between Alzheimer's Disease and Type 2 Diabetes.
    Michailidis M; Moraitou D; Tata DA; Kalinderi K; Papamitsou T; Papaliagkas V
    Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin, insulin-degrading enzyme and amyloid-beta peptide in Alzheimer's disease: review and hypothesis.
    Qiu WQ; Folstein MF
    Neurobiol Aging; 2006 Feb; 27(2):190-8. PubMed ID: 16399206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A systematic literature review of the effect of insulin sensitizers on the cognitive symptoms of Alzheimer's Disease in transgenic mice.
    Craig A; Parvez F; Issberner J
    Behav Brain Res; 2019 Oct; 372():112015. PubMed ID: 31255671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism involved in insulin resistance via accumulation of β-amyloid and neurofibrillary tangles: link between type 2 diabetes and Alzheimer's disease.
    Rad SK; Arya A; Karimian H; Madhavan P; Rizwan F; Koshy S; Prabhu G
    Drug Des Devel Ther; 2018; 12():3999-4021. PubMed ID: 30538427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin deficiency promotes formation of toxic amyloid-β42 conformer co-aggregating with hyper-phosphorylated tau oligomer in an Alzheimer's disease model.
    Imamura T; Yanagihara YT; Ohyagi Y; Nakamura N; Iinuma KM; Yamasaki R; Asai H; Maeda M; Murakami K; Irie K; Kira JI
    Neurobiol Dis; 2020 Apr; 137():104739. PubMed ID: 31927145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Link between Type 2 Diabetes and Neurodegeneration: Roles for Amyloid-β, Amylin, and Tau Proteins.
    Bharadwaj P; Wijesekara N; Liyanapathirana M; Newsholme P; Ittner L; Fraser P; Verdile G
    J Alzheimers Dis; 2017; 59(2):421-432. PubMed ID: 28269785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting Insulin-Degrading Enzyme to Treat Type 2 Diabetes Mellitus.
    Tang WJ
    Trends Endocrinol Metab; 2016 Jan; 27(1):24-34. PubMed ID: 26651592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Insulin Degrading Enzyme and Neprilysin in Alzheimer's Disease Biology: Characterization of Putative Cognates for Therapeutic Applications.
    Jha NK; Jha SK; Kumar D; Kejriwal N; Sharma R; Ambasta RK; Kumar P
    J Alzheimers Dis; 2015; 48(4):891-917. PubMed ID: 26444774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin resistance and amyloidogenesis as common molecular foundation for type 2 diabetes and Alzheimer's disease.
    Zhao WQ; Townsend M
    Biochim Biophys Acta; 2009 May; 1792(5):482-96. PubMed ID: 19026743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metformin attenuates vascular pathology by increasing expression of insulin-degrading enzyme in a mixed model of cerebral amyloid angiopathy and type 2 diabetes mellitus.
    Inoue Y; Masuda T; Misumi Y; Ando Y; Ueda M
    Neurosci Lett; 2021 Sep; 762():136136. PubMed ID: 34311050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetes-associated SorCS1 regulates Alzheimer's amyloid-beta metabolism: evidence for involvement of SorL1 and the retromer complex.
    Lane RF; Raines SM; Steele JW; Ehrlich ME; Lah JA; Small SA; Tanzi RE; Attie AD; Gandy S
    J Neurosci; 2010 Sep; 30(39):13110-5. PubMed ID: 20881129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in insulin and insulin signaling in Alzheimer's disease: cause or consequence?
    Stanley M; Macauley SL; Holtzman DM
    J Exp Med; 2016 Jul; 213(8):1375-85. PubMed ID: 27432942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Agmatine ameliorates type 2 diabetes induced-Alzheimer's disease-like alterations in high-fat diet-fed mice via reactivation of blunted insulin signalling.
    Kang S; Kim CH; Jung H; Kim E; Song HT; Lee JE
    Neuropharmacology; 2017 Feb; 113(Pt A):467-479. PubMed ID: 27810390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GLP-1 receptor stimulation reduces amyloid-beta peptide accumulation and cytotoxicity in cellular and animal models of Alzheimer's disease.
    Li Y; Duffy KB; Ottinger MA; Ray B; Bailey JA; Holloway HW; Tweedie D; Perry T; Mattson MP; Kapogiannis D; Sambamurti K; Lahiri DK; Greig NH
    J Alzheimers Dis; 2010; 19(4):1205-19. PubMed ID: 20308787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated glucose and oligomeric β-amyloid disrupt synapses via a common pathway of aberrant protein S-nitrosylation.
    Akhtar MW; Sanz-Blasco S; Dolatabadi N; Parker J; Chon K; Lee MS; Soussou W; McKercher SR; Ambasudhan R; Nakamura T; Lipton SA
    Nat Commun; 2016 Jan; 7():10242. PubMed ID: 26743041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.